Login
← Go Back
Torrent Pharmaceuticals
TORNTPHARM · Pharma > Pharmaceuticals & Drugs · Chairman: Samir Mehta Listing date: Oct. 24, 1994 · Employees: 13505 · Ahmedabad · http://www.torrentpharma.com
Stock Price vs Company Growth
1d
-0.0%
1w
2.8%
1m
3.1%
3m
0.0%
6m
4.7%
1y
25.3%
5y
24.0%
10y
20.4%
all
27.4%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowDec10Jun14Dec17Jun21Latest
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 3,334 -0.0%
2,891
3,370
Company Overview
Sales
11,302 Cr
Growth: 9.7%
Profit after Tax
1,862 Cr
Growth: 8.6%
Large Cap
1,12,855 Cr
P/E: 60.7x
Industry P/E: 30.7x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals
Sales (Cr) ₹ 11,302
Growth 9.7%
EBITDA 32.2%
P/S 10.0x
Dividend 1.0%
P/E 60.7x
Book Value ₹ 244
PEG Ratio 6.3x
ROE 24.7%
P/B 13.6x
Shareholding Pattern
Institutions
Mirae Asset Focused Fund
2.16 %
Qualified Institutional Buyer
1.63 %
Uti-Unit Linked Insurance Plan
1.28 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Jun21Dec22Sep23Dec24
Promoters
Torrent Investments Private Limited
71.25 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Jun21Dec22Sep23Dec24
Others
Ifpf
0.1 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Jun21Dec22Sep23Dec24
Increase    Decrease    No change
Company Profile Detailed
Torrent Pharmaceuticals has established itself as a major player in the Indian Pharma arena. The company has well segregated marketing divisions, strategically structured on specific therapeutic areas and enjoys dominance in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC).
Belongs to (39 Indices) view more
Investors (89)
mirae.as...
ishares....
ruchir.m...
Followers (13)
nitin2
keerthi
deepak